Skull Base Chordomas and Chondrosarcomas

Skull Base Chordomas and Chondrosarcomas

Skull Base Chordomas and Chondrosarcomas

On this page

Introduction: Chordoma vs Chondrosarcoma - Tale of Two Tumors

FeatureChordomaChondrosarcoma
OriginNotochordal remnantsCartilage (synchondroses)
LocationMidline: Clivus, SacrumOff-midline: Petroclival, Parasellar
Age PeakBimodal: 30s & 50-60 yrs30-40 yrs
Key HistoPhysaliphorous cells (bubbly)Chondroid matrix, lobulated, +/- atypia
BehaviorLocally aggressive, destructiveOften slow-growing, locally invasive
Mnemonic 📌Clivus, Central, NotochordCartilage, Off-midline

⭐ Chordomas are slow-growing malignant tumors from embryonic notochordal remnants, most common in clivus/sacrum, typically midline.

Clinical Presentation & Diagnosis: Skull Base Tumors - Unmasking the Culprits

  • Clinical Presentation: Insidious onset; symptoms location-dependent.
    • Cranial Nerve (CN) Palsies: Most frequent.
      • Diplopia (CN VI), facial pain/numbness (CN V), hoarseness (CN IX, X). 📌 VI for VIsion double.
    • Headache: Persistent, deep-seated.
    • Nasal Symptoms: Obstruction, epistaxis (with anterior extension).
    • Brainstem Signs (late): Ataxia, motor deficits.
  • Diagnosis:
    • Neuroimaging:
      • MRI:
        • Chordoma: Midline (clivus), destructive, T2 hyperintense, avid enhancement.
        • Chondrosarcoma: Off-midline (petroclival), T2 hyperintense, "rings & arcs" calcification (CT better for Ca++).
      • CT Scan: Details bony erosion, calcifications.
    • Biopsy & Histopathology: Essential for confirmation.
      • Chordoma: Physaliphorous cells (bubbly cytoplasm).
      • Chondrosarcoma: Malignant chondrocytes in cartilaginous matrix.

⭐ MRI is the gold standard for diagnosis and delineating tumor extent, especially its relationship with neurovascular structures.

Skull base chordoma vs chondrosarcoma imaging

Histopathology & Molecular Markers: Tumor Signatures - Cellular Clues

FeatureChordomaChondrosarcoma
Key CellsPhysaliphorous cells (vacuolated, "soap-bubble" appearance)Atypical chondrocytes in cartilage matrix
StromaMyxoid/chondromyxoidHyaline cartilaginous matrix
Growth PatternLobulatedLobular; graded (cellularity, atypia, mitoses)
IHC: BrachyuryPositive (nuclear)Negative
IHC: CytokeratinPositiveNegative
IHC: S100PositivePositive

⭐ Brachyury (TBXT) nuclear staining is a highly specific and sensitive marker for chordoma, crucial for differentiating it from chondrosarcoma.

  • Chordoma variants: Conventional, chondroid (S100+, CK+, Brachyury+), dedifferentiated.
  • Chondrosarcoma grading (Evans): Grade I, II, III based on cellularity, atypia, mitotic activity.

Management & Prognosis: Skull Base Lesions - Battling the Base

  • Goal: Maximal safe resection & adjuvant radiotherapy (RT).
  • Surgical Approaches:
    • Endoscopic Endonasal Approach (EEA): Preferred for midline lesions (clivus, sella).
      • Surgical approaches for skull base tumors
    • Open craniotomy: For lateral/complex extensions.
  • Radiotherapy: Crucial for local control.
    • Proton Beam Therapy (PBT): Preferred for chordomas due to Bragg peak precision, minimizing dose to surrounding critical structures. Dose: ~70-80 GyE.
    • Photon RT (IMRT/Stereotactic): For chondrosarcomas or when PBT unavailable.
  • Prognosis:
    • Chordomas: Locally aggressive, high recurrence. 5-yr survival ~50-70%.
    • Chondrosarcomas: More indolent, better prognosis. 5-yr survival ~80-90%.
    • Negative factors: Large size, brainstem involvement, incomplete resection, RT delays.

⭐ For skull base chordomas, maximal safe surgical resection followed by high-dose adjuvant radiotherapy (preferably proton beam therapy) is the standard of care and offers the best local control.

📌 Chordoma = Clivus common, Challenging, Consider PBT. Chondrosarcoma = Cartilaginous, Comparatively better prognosis.

High‑Yield Points - ⚡ Biggest Takeaways

  • Chordomas: Notochord remnants, midline (clivus). Chondrosarcomas: Cartilage origin, often off-midline (petroclival).
  • Symptoms: Cranial nerve palsies (esp. VI nerve), headaches.
  • Chordomas: Physaliphorous cells; midline destructive, T2 hyperintense on MRI.
  • Chondrosarcomas: Malignant chondrocytes; may show chondroid matrix calcification (rings/arcs).
  • Treatment: Maximal safe resection + adjuvant radiotherapy (proton beam for chordomas).
  • Chondrosarcomas have better prognosis; Chordomas show high local recurrence.

Practice Questions: Skull Base Chordomas and Chondrosarcomas

Test your understanding with these related questions

What is the most common structural location within the bone for conventional chondrosarcoma?

1 of 5

Flashcards: Skull Base Chordomas and Chondrosarcomas

1/6

The size of the nasal meningocele increasing in response to _____ is also known as a positive frustenberg test

TAP TO REVEAL ANSWER

The size of the nasal meningocele increasing in response to _____ is also known as a positive frustenberg test

coughing

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial